Health
‘The silent pandemic’: A hotter world makes it harder to stop the spread of deadly superbugs
A microbiologist at the Max-Planck-Institute for Infection Biology prepares a bacterial colony of the strain Streptococcus pyogenes on a blood agar plate. Picture Alliance | Picture Alliance | Getty Images Already recognized as one of the leading public health threats facing humanity today, it is feared that a warming world is making it harder to stop […]
Read More
CDC expedites release of more doses of infant RSV drug from Sanofi, AstraZeneca amid shortage
A RSV-infected child receives treatment, as RS-Virus infections spread among children at Missio children’s clinic Moenchberg, in Wuerzburg, Germany, December 2, 2022. Heiko Becker | Reuters The Centers for Disease Control and Prevention expedited the release of more than 77,000 additional doses of a new drug designed to protect infants from respiratory syncytial virus amid […]
Read More
Here’s what Wall Street is saying about obesity drug Wegovy following Novo Nordisk’s key study
Analysts are largely optimistic about a new class of anti-obesity medications following a landmark study released over the weekend. Novo Nordisk ‘s Select study of about 17,500 people found the use of its Wegovy decreased the risk of serious cardiovascular complications such as heart attacks. The study, which was shared at the American Heart Association […]
Read More
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
CFOTO | Future Publishing | Getty Images As its Covid gains evaporate, Pfizer wants a chunk of the budding weight loss drug market. Analysts say upcoming data on Pfizer’s experimental obesity pill, danuglipron, will be crucial in determining how competitive the company can be against the space’s dominant players Eli Lilly and Novo Nordisk. Those […]
Read More
Amputees say this bionic hand startup gives them both strength and grace — they can even pick up raw eggs without crushing them
Andrew Hitz with the Zeus hand. Courtesy of Aether Biomedical In 2011, Jeremy Schroeder was driving a four-wheeler near Sherwood, Ohio, when he crashed into a stop sign he hadn’t seen as the stone path suddenly turned to asphalt. The sign left a deep gash in Schroeder’s arm; he was rapidly losing blood. Shroeder, who […]
Read More
Novo Nordisk’s weight loss drug Wegovy slashes risk of serious heart events
Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity. Michael Siluk | UCG | Getty Images Novo Nordisk’s Wegovy cut the risk of serious cardiovascular complications in people with obesity and heart disease in a closely […]
Read More
Lilly trades at a premium to Ozempic-maker Novo as obesity drugs boom. Here’s why, analyst says
Does Eli Lilly deserve to trade at a premium to Novo Nordisk shares? For Deutsche Bank analyst James Shin, the answer is: “yes, but not to this degree.” Shin initiated coverage of a host of pharmaceutical stocks, including Eli Lilly, on Wednesday. The analyst said he is worried Lilly’s valuation is “grating against fundamentals,” as […]
Read More
Patients are lining up for $2,500 full-body MRI scans that can detect cancer early
Prenuvo MRI machine Courtesy of Prenuvo While celebrating the July Fourth holiday last year on a boat in Tyler, Texas, Dr. Julianne Santarosa received the results from her full-body MRI scan. What she saw put a damper on the festivities. Radiologists at Prenuvo, which performed the scan, had identified a nodule in her lungs. Santarosa, […]
Read More
Amazon adds a new reason to get and keep Prime: member discounts on health-care services
Amazon (AMZN) said on Wednesday that it’s offering Prime members a discount on its new health-care service — another perk that should help bring more people into the online retailer’s ecosystem. The One Medical service, which typically costs $199 annually, will be available to Prime subscribers for $9 a month or $99 per year. It […]
Read More
FDA approves Eli Lilly’s tirzepatide for weight loss, paving way for wider use of blockbuster drug
A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, on March 29, 2023. George Frey | Reuters The Food and Drug Administration on Wednesday approved Eli Lilly‘s blockbuster drug tirzepatide for weight loss, paving the way for […]
Read More